RB1 and neoplasm: MCPyV-negative MCCs commonly have loss-of-function RB1 mutation, and RB expression is undetectable in those MCC, whereas integration of MCPyV large T antigen in the RB promoter region is frequently found in MCPyV-positive tumor cells [46,47].